Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.87

-2.3%

Dec 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who started this subject	8/26/2001 11:30:06 PM
From: schzammm	Read Replies (1) of 52153

I don't know if anyone might be interested, but I have found a Canadian biotechnology company (Isotechnika, traded on the Toronto Stock Exchange isa.to, t.isa) that has discovered an alternative drug to replace cyclosporine. Cyclosporine currently has annual worldwide sales approaching $2B. Isa just started PhaseII clinical in the U.S. and Canada for kidney transplant rejection. The market which isa is targeting, replacing cyclosproine with a more potent and less toxic alternative has a current market approaching $2B (worldwide). Isa will begin PhaseII clinical trials for Rheumatoid Arthritis and another trial for Psoriasis before the end of 2001. I bring Isa to your attention because at $C5.00 and $3.25, I believe the stock to be exteremly undervalued. I started a thread under Isotechnika but after a month I am still posting to myself. What I would really appreciate is someone taking a look at Isotechnika and sharing their analysis of the company and their valuation. On the Isotechnika board I list the home page and another link to a recent news release. I really believe that anyone who will take the time to research this company will be surprised at the current low valuation. If you don't agree I have thick skin and would appreciate hearing why you think the company is not undervalued or a pos, whatever. It is just that sometimes one comes across what seems to be a truely great undervalued company and just want to hear some confirmation or someone to point out the flaws.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next